B6.129P2(C)-Pik3cdtm1.1Bvan/Orl

Status

Available to order

EMMA IDEM:11499
International strain nameB6.129P2(C)-Pik3cdtm1.1Bvan/Orl
Alternative namep110delta PI3K-D910A-Myc (B6)
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolPik3cdtm1.1Bvan
Gene/Transgene symbolPik3cd

Information from provider

ProviderBart Vanhaesebroeck
Provider affiliationUCL Cancer Institute, University College London
Additional ownerCo-developed by the Ludwig Institute for Cancer Research (LICR) and the University of Edinburgh, UK. The materials are available to academic researchers. Commercial entity need to obtain a licensing agreement.
Genetic informationKnock-in mice in which the endogenous PIK3CD/p110delta PI3K gene is mutated so that it now encodes a p110delta protein with (1) the D910A mutation in the ATP binding site, converting it to a kinase-dead p110delta protein which is expressed at the same level as wild-type p110delta; (2) a C-terminal Myc-epitope tag. Backcrossed onto C57BL/6J background.
Phenotypic informationHomozygous:
Mice have altered immune system and can develop colitis.

Heterozygous:
Mice show intermediate phenotypes between homozygous knock-in and wild-type but this has not been extensively characterised (see Fig. 2A in PMID 16179367)
Breeding historyBackcrossed onto C57BL/6J for more than 10 generations.
References
  • Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.;Okkenhaug Klaus, Bilancio Antonio, Farjot Géraldine, Priddle Helen, Sancho Sara, Peskett Emma, Pearce Wayne, Meek Stephen E, Salpekar Ashreena, Waterfield Michael D, Smith Andrew J H, Vanhaesebroeck Bart, ;2002;Science (New York, N.Y.);297;1031-4; 12130661
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedyes

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

MGI phenotypes (allele matching)
  • abnormal platelet aggregation / MGI
  • cardiovascular system phenotype / MGI
  • increased neutrophil cell number / MGI
  • abnormal intestinal epithelium morphology / MGI
  • crypts of Lieberkuhn abscesses / MGI
  • abnormal intestinal mucosa morphology / MGI
  • spleen hypoplasia / MGI
  • decreased IgM level / MGI
  • decreased IgA level / MGI
  • intestinal inflammation / MGI
  • abnormal B cell differentiation / MGI
  • abnormal Peyer's patch germinal center morphology / MGI
  • decreased immunoglobulin level / MGI
  • decreased B-1 B cell number / MGI
  • absent spleen germinal center / MGI
MGI phenotypes (gene matching)
  • increased leukocyte cell number / MGI
  • increased neutrophil cell number / MGI
  • abnormal intestinal epithelium morphology / MGI
  • crypts of Lieberkuhn abscesses / MGI
  • abnormal intestinal mucosa morphology / MGI
  • small spleen / MGI
  • spleen hypoplasia / MGI
  • impaired hematopoiesis / MGI
  • abnormal humoral immune response / MGI
  • decreased IgG level / MGI
  • decreased IgM level / MGI
  • decreased IgA level / MGI
  • intestinal inflammation / MGI
  • decreased inflammatory response / MGI
  • abnormal B cell differentiation / MGI
  • small lymph nodes / MGI
  • abnormal Peyer's patch germinal center morphology / MGI
  • increased susceptibility to viral infection / MGI
  • abnormal B cell physiology / MGI
  • decreased immunoglobulin level / MGI
  • increased IgE level / MGI
  • no phenotypic analysis / MGI
  • decreased susceptibility to induced arthritis / MGI
  • decreased B-1 B cell number / MGI
  • increased lymphocyte cell number / MGI
  • decreased B cell number / MGI
  • decreased B cell proliferation / MGI
  • cardiovascular system phenotype / MGI
  • immune system phenotype / MGI
  • decreased B-1a cell number / MGI
  • decreased marginal zone B cell number / MGI
  • absent B-1 B cells / MGI
  • decreased B-2 B cell number / MGI
  • decreased mature B cell number / MGI
  • absent spleen germinal center / MGI
  • decreased IgG1 level / MGI
  • decreased IgG2a level / MGI
  • decreased IgG2b level / MGI
  • decreased IgG3 level / MGI
  • increased circulating interferon-alpha level / MGI
  • abnormal platelet aggregation / MGI
  • decreased response to antigen / MGI
  • increased response to antigen / MGI

Literature references

  • Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.;Okkenhaug Klaus, Bilancio Antonio, Farjot Géraldine, Priddle Helen, Sancho Sara, Peskett Emma, Pearce Wayne, Meek Stephen E, Salpekar Ashreena, Waterfield Michael D, Smith Andrew J H, Vanhaesebroeck Bart, ;2002;Science (New York, N.Y.);297;1031-4; 12130661

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).